RESEARCH

CJC-1295 and Ipamorelin

Combination laboratory standard. Not for human use.

Net content
- 10 mg (5+5)
- 20 mg (10+10)
Dosage form
- Lyophilizate

This combination does not exist.

Copy Link

Link Copied

Dosage form: Lyophilizate

Category :

GH secretagogues and GHRH analogues Combination standards (blends)

Services :

For research only
Certificate and HPLC
CDEK delivery worldwide

Description

A combination standard: a GHRH analogue (CJC-1295) and a GHRP-class peptide (Ipamorelin) in one vial at a fixed ratio.

Supply form

Lyophilised powder in a vial. The composition and mass of each component are stated in the selected variant and the batch documents.

Quality control and documents

A certificate of analysis (COA) and safety data sheet (SDS) are available for the batch on request, where applicable. Organisations receive an invoice and closing documents.

Storage

Store in a closed vial, in a dry place protected from light, at the temperature stated in the batch specification.

Intended use

For laboratory research only. Not a medicinal product or dietary supplement; not for human or veterinary use.

Intended use

For research only

Products are intended exclusively for laboratory and scientific research (For Research Use Only · Not for Human Use).

Not a medicinal product, dietary supplement, or food. Not for use in humans or animals for therapeutic purposes.

Protocol

Laboratory protocol

Material for laboratory protocols. Not instructions for use in humans.

Lyophilizate: reconstitute only under controlled laboratory conditions, per internal SOP and the batch COA.
Ready research form: use only within a laboratory protocol.

Storage

Store per the batch COA, in the original packaging, protected from light and moisture.